296 related articles for article (PubMed ID: 28800164)
1. B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.
Becerra E; De La Torre I; Leandro MJ; Cambridge G
Clin Exp Immunol; 2017 Dec; 190(3):372-383. PubMed ID: 28800164
[TBL] [Abstract][Full Text] [Related]
2. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.
Cambridge G; Perry HC; Nogueira L; Serre G; Parsons HM; De La Torre I; Dickson MC; Leandro MJ; Edwards JC
J Autoimmun; 2014 May; 50():67-76. PubMed ID: 24365380
[TBL] [Abstract][Full Text] [Related]
3. B cell activating factor (BAFF) and BAFF receptors: fakes and facts.
Ferraccioli G; Gremese E
Clin Exp Immunol; 2017 Dec; 190(3):291-292. PubMed ID: 28834574
[TBL] [Abstract][Full Text] [Related]
4. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
5. B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy.
de la Torre I; Moura RA; Leandro MJ; Edwards J; Cambridge G
Ann Rheum Dis; 2010 Dec; 69(12):2181-8. PubMed ID: 20581016
[TBL] [Abstract][Full Text] [Related]
6. Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.
Becerra E; Scully MA; Leandro MJ; Heelas EO; Westwood JP; De La Torre I; Cambridge G
Clin Exp Immunol; 2015 Mar; 179(3):414-25. PubMed ID: 25339550
[TBL] [Abstract][Full Text] [Related]
7. BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis.
Moura RA; Canhão H; Polido-Pereira J; Rodrigues AM; Navalho M; Mourão AF; Resende C; Campanilho-Marques R; Madruga Dias J; da Silva JA; Graca L; Fonseca JE
J Rheumatol; 2013 Aug; 40(8):1293-302. PubMed ID: 23772083
[TBL] [Abstract][Full Text] [Related]
8. BAFF- and TACI-Dependent Processing of BAFFR by ADAM Proteases Regulates the Survival of B Cells.
Smulski CR; Kury P; Seidel LM; Staiger HS; Edinger AK; Willen L; Seidl M; Hess H; Salzer U; Rolink AG; Rizzi M; Schneider P; Eibel H
Cell Rep; 2017 Feb; 18(9):2189-2202. PubMed ID: 28249164
[TBL] [Abstract][Full Text] [Related]
9. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
Sellam J; Rouanet S; Hendel-Chavez H; Abbed K; Sibilia J; Tebib J; Le Loët X; Combe B; Dougados M; Mariette X; Taoufik Y
Arthritis Rheum; 2011 Dec; 63(12):3692-701. PubMed ID: 22127692
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
11. BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis.
Zhang LL; Xiao H; Zhang F; Wu YJ; Shu JL; Li Y; Tai Y; Xu SQ; Xu JH; Wei W
Acta Pharmacol Sin; 2021 Oct; 42(10):1665-1675. PubMed ID: 33483588
[TBL] [Abstract][Full Text] [Related]
12. CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism.
Nelke J; Medler J; Weisenberger D; Beilhack A; Wajant H
MAbs; 2020; 12(1):1807721. PubMed ID: 32840410
[TBL] [Abstract][Full Text] [Related]
13. BAFF receptor and TACI in B-1b cell maintenance and antibacterial responses.
Dickinson GS; Akkoyunlu M; Bram RJ; Alugupalli KR
Ann N Y Acad Sci; 2015 Dec; 1362():57-67. PubMed ID: 25962322
[TBL] [Abstract][Full Text] [Related]
14. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
15. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
[TBL] [Abstract][Full Text] [Related]
16. [Role of B-cell-activating-factor in immune regulation--review].
Du JF; Wang JX; Xu DG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):631-4. PubMed ID: 16800959
[TBL] [Abstract][Full Text] [Related]
17. The Correlation Between Non-Hodgkin Lymphoma and Expression Levels of B-Cell Activating Factor and Its Receptors.
Shen X; Wang M; Guo Y; Ju S
Adv Clin Exp Med; 2016; 25(5):837-844. PubMed ID: 28028945
[TBL] [Abstract][Full Text] [Related]
18. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
[TBL] [Abstract][Full Text] [Related]
19. Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis.
Chang Y; Sun X; Jia X; Xu S; Wei F; Yang X; Wei W
Int Immunopharmacol; 2015 Feb; 24(2):451-457. PubMed ID: 25598291
[TBL] [Abstract][Full Text] [Related]
20. BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.
Treml LS; Crowley JE; Cancro MP
Semin Immunol; 2006 Oct; 18(5):297-304. PubMed ID: 16919470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
